Marsh & Mclennan Companies (MRSH) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
MRSH jumps 4.6% to $186.54, a 1-month high, 4 up days in a row. Closed at $186.54, +4.56% vs the prior close of $178.40. Day range $181.20–$191.04, opened at $182.80.
MRSH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MRSH jumps 4.6% to $186.54, a 1-month high, 4 up days in a row
- Closed at $186.54, +4.56% vs the prior close of $178.40. Day range $181.20–$191.04, opened at $182.80.
- Volume was 4.23M shares, 1.8x its 50-day average of 2.41M.
- Price is +2.8% vs its 50-day average ($181.38) and +5.6% vs its 200-day average ($176.70).
- 52-week range $156.60–$206.04; today's close sits at 61% of that range, 9.5% below the 52-week high.
- That makes 4 straight gains.
- SEC filings that day: 10-Q, 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 14, 2026 — MRSH rises 0.8% to $178.40, 3 up days in a row
- Closed at $178.40, +0.79% vs the prior close of $177.01. Day range $176.44–$179.40, opened at $178.52.
- Volume was 2.47M shares, 1.0x its 50-day average of 2.41M.
- Price is -1.7% vs its 50-day average ($181.48) and +1.0% vs its 200-day average ($176.70).
- 52-week range $156.60–$207.28; today's close sits at 43% of that range, 13.9% below the 52-week high.
- That makes 3 straight gains.
Oct 13, 2026 — MRSH ends flat (+0.3%) to $177.01
- Closed at $177.01, +0.27% vs the prior close of $176.54. Day range $175.80–$178.34, opened at $177.63.
- Volume was 3.66M shares, 1.5x its 50-day average of 2.38M.
- Price is -2.6% vs its 50-day average ($181.74) and +0.1% vs its 200-day average ($176.75).
- 52-week range $156.60–$207.28; today's close sits at 40% of that range, 14.6% below the 52-week high.
Oct 12, 2026 — MRSH rises 0.4% to $176.54
- Closed at $176.54, +0.44% vs the prior close of $175.76. Day range $175.42–$176.70, opened at $176.28.
- Volume was 2.35M shares, 1.0x its 50-day average of 2.38M.
- Price is -3.0% vs its 50-day average ($182.05) and -0.1% vs its 200-day average ($176.80).
- 52-week range $156.60–$207.83; today's close sits at 39% of that range, 15.1% below the 52-week high.
Oct 9, 2026 — MRSH dips 0.5% to $175.76
- Closed at $175.76, -0.52% vs the prior close of $176.67. Day range $175.41–$177.79, opened at $175.64.
- Volume was 1.97M shares, 0.8x its 50-day average of 2.42M.
- Price is -3.6% vs its 50-day average ($182.32) and -0.6% vs its 200-day average ($176.85).
- 52-week range $156.60–$207.83; today's close sits at 37% of that range, 15.4% below the 52-week high.
Oct 8, 2026 — MRSH rises 1.7% to $176.67, 4 up days in a row
- Closed at $176.67, +1.73% vs the prior close of $173.66. Day range $172.79–$176.86, opened at $174.28.
- Volume was 3.95M shares, 1.6x its 50-day average of 2.44M.
- Price is -3.3% vs its 50-day average ($182.63) and -0.1% vs its 200-day average ($176.89).
- 52-week range $156.60–$207.83; today's close sits at 39% of that range, 15.0% below the 52-week high.
- That makes 4 straight gains.
Oct 7, 2026 — MRSH rises 1.1% to $173.66, 3 up days in a row
- Closed at $173.66, +1.12% vs the prior close of $171.74. Day range $166.48–$173.95, opened at $172.35.
- Volume was 2.73M shares, 1.1x its 50-day average of 2.48M.
- Price is -5.1% vs its 50-day average ($183.05) and -1.9% vs its 200-day average ($176.93).
- 52-week range $156.60–$207.83; today's close sits at 33% of that range, 16.4% below the 52-week high.
- That makes 3 straight gains.
Oct 6, 2026 — MRSH rises 0.8% to $171.74
- Closed at $171.74, +0.77% vs the prior close of $170.43. Day range $169.52–$172.39, opened at $169.76.
- Volume was 1.97M shares, 0.8x its 50-day average of 2.48M.
- Price is -6.4% vs its 50-day average ($183.42) and -3.0% vs its 200-day average ($176.99).
- 52-week range $156.60–$207.83; today's close sits at 30% of that range, 17.4% below the 52-week high.
Oct 5, 2026 — MRSH ends flat (+0.2%) to $170.43
- Closed at $170.43, +0.22% vs the prior close of $170.06. Day range $168.31–$171.31, opened at $169.62.
- Volume was 2.11M shares, 0.9x its 50-day average of 2.48M.
- Price is -7.2% vs its 50-day average ($183.65) and -3.7% vs its 200-day average ($177.07).
- 52-week range $156.60–$207.83; today's close sits at 27% of that range, 18.0% below the 52-week high.
Oct 2, 2026 — MRSH dips 1.0% to $170.06
- Closed at $170.06, -1.04% vs the prior close of $171.85. Day range $169.28–$172.43, opened at $171.33.
- Volume was 2.93M shares, 1.2x its 50-day average of 2.48M.
- Price is -7.5% vs its 50-day average ($183.86) and -4.0% vs its 200-day average ($177.15).
- 52-week range $156.60–$207.83; today's close sits at 26% of that range, 18.2% below the 52-week high.
MRSH latest news & SEC filings
Every SEC filing by or about MRSH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Sep 30, 2026:
- Revenue: $6.86B (prior year $6.35B) (+8.1% vs Sep 30, 2025)
- Net income: $808.00M (prior year $747.00M) (+8.2% vs Sep 30, 2025)
- Diluted EPS: $1.69 (prior year $1.51) (+11.9% vs Sep 30, 2025)
Oct 15, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Sep 21, 2026 · 25-NSE — Notice that a security is being removed from exchange listing
Notice that a security is being removed from exchange listing
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Brennan Katherine sold 1,197 shares at $187.90 (≈$224.92K) on Sep 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Doyle John Q sold 16,656 shares at $188.51 (≈$3.14M) on Sep 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 2, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 2, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 18, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 18, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 21, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $7.40B (prior year $6.97B) (+6.2% vs Jun 30, 2025)
- Net income: $1.27B (prior year $1.21B) (+4.5% vs Jun 30, 2025)
- Diluted EPS: $2.63 (prior year $2.45) (+7.3% vs Jun 30, 2025)
Jul 21, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 22, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Jun 22, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade MRSH
- Last results release: Oct 15, 2026 (8-K Item 2.02). Previous ones: Jul 21, 2026, Apr 16, 2026, Jan 29, 2026. Based on that rhythm, the next report is likely around Jan 14, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.93% (largest 4.6%). That is a relatively calm stock.
- Liquidity: about 3.09M shares (≈$576.76M) trade per day on average.
- 52-week position: $186.54 vs a range of $156.60–$206.04 (61% of the range).
- Dividends: last ex-dividend date Oct 1, 2026 ($0.99/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 11 sales; latest: John Q Doyle sold 16,656 shares on Sep 2, 2026.
- Latest filings: 10-Q Oct 15, 2026; 8-K Oct 15, 2026; 10-Q Jul 21, 2026.
- Share count: 475.51M shares outstanding (Oct 12, 2026), -2.9% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Insurance Agents, Brokers & Service.
MRSH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 182.80 | 191.04 | 181.20 | 186.54 | 4.23M |
| Oct 14, 2026 | 178.52 | 179.40 | 176.44 | 178.40 | 2.47M |
| Oct 13, 2026 | 177.63 | 178.34 | 175.80 | 177.01 | 3.66M |
| Oct 12, 2026 | 176.28 | 176.70 | 175.42 | 176.54 | 2.35M |
| Oct 9, 2026 | 175.64 | 177.79 | 175.41 | 175.76 | 1.97M |
| Oct 8, 2026 | 174.28 | 176.86 | 172.79 | 176.67 | 3.95M |
| Oct 7, 2026 | 172.35 | 173.95 | 166.48 | 173.66 | 2.73M |
| Oct 6, 2026 | 169.76 | 172.39 | 169.52 | 171.74 | 1.97M |
| Oct 5, 2026 | 169.62 | 171.31 | 168.31 | 170.43 | 2.11M |
| Oct 2, 2026 | 171.33 | 172.43 | 169.28 | 170.06 | 2.93M |
| Oct 1, 2026 | 169.97 | 172.27 | 169.97 | 171.85 | 2.25M |
| Sep 30, 2026 | 170.01 | 171.66 | 169.28 | 170.73 | 3.09M |
| Sep 29, 2026 | 167.24 | 171.07 | 167.24 | 170.42 | 3.57M |
| Sep 28, 2026 | 171.17 | 171.67 | 168.49 | 169.03 | 1.92M |
| Sep 25, 2026 | 169.95 | 173.74 | 169.67 | 171.12 | 3.15M |
| Sep 24, 2026 | 170.81 | 171.84 | 168.92 | 169.93 | 3.20M |
| Sep 23, 2026 | 169.45 | 171.52 | 169.45 | 170.38 | 2.65M |
| Sep 22, 2026 | 172.85 | 172.91 | 167.93 | 170.01 | 3.62M |
| Sep 21, 2026 | 175.16 | 175.79 | 172.72 | 172.72 | 2.86M |
| Sep 18, 2026 | 173.76 | 176.24 | 172.63 | 175.01 | 7.17M |
About Marsh & Mclennan Companies
Marsh & Mclennan Companies (MRSH) is listed on the NYSE and classified by the SEC under “Insurance Agents, Brokers & Service”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 62709.
MRSH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Anthony Anderson | Director | Aug 18, 2026 |
| Bruce D Broussard | Director | Aug 18, 2026 |
| H Edward Hanway | Director | Jun 3, 2026 |
| Deborah C Hopkins | Director | Aug 18, 2026 |
| Peter Harrison | Director | Jun 3, 2026 |
| Judith Hartmann | Director | Jun 3, 2026 |
| Tamara Ingram | Director | Aug 18, 2026 |
| Jane H Lute | Director | Aug 18, 2026 |
| Steven A Mills | Director | Aug 18, 2026 |
| Morton O Schapiro | Director | Aug 18, 2026 |
| Jan Siegmund | Director | Aug 18, 2026 |
| Lloyd M Yates | Director | Aug 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Paul Beswick | SVP, Chief Information Officer | Jul 31, 2026 |
| Katherine Brennan | SVP and General Counsel | Sep 3, 2026 |
| John Q Doyle | President and CEO | Sep 3, 2026 |
| Carmen Fernandez | SVP, Chief People Officer | May 1, 2026 |
| John Jude Jones | Chief Marketing Officer | Aug 7, 2026 |
| Dean Michael Klisura | President & CEO, Guy Carpenter | May 1, 2026 |
| Mark C Mcgivney | EVP, CFO and COO | May 1, 2026 |
| Stacy Mills | Vice President and Controller | Mar 3, 2026 |
| Edward Francis Moynihan | President & CEO, Oliver Wyman | Apr 10, 2026 |
| Martin South | Chief Client Officer | Jul 29, 2026 |
| Nicholas Mark Studer | President and CEO Marsh Risk | May 1, 2026 |
| Patrick Tomlinson | President and CEO, Mercer | May 1, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | John Q Doyle | Sale | 16,656 | $188.51 |
| Sep 2, 2026 | Katherine Brennan | Sale | 1,197 | $187.90 |
| Aug 6, 2026 | John Jude Jones | Sale | 6,500 | $191.96 |
| Jul 29, 2026 | Paul Beswick | Sale | 713 | $198.00 |
| Jul 28, 2026 | Martin South | Sale | 7,100 | $189.99 |
| Jul 23, 2026 | Lloyd M Yates | Sale | 12,000 | $175.65 |
| Jun 2, 2026 | John Q Doyle | Sale | 16,656 | $161.71 |
| Mar 11, 2026 | John Jude Jones | Sale | 2,362 | $173.61 |
| Mar 4, 2026 | John Q Doyle | Sale | 16,655 | $183.30 |
| Mar 3, 2026 | Nicholas Mark Studer | Sale | 3,837 | $184.03 |
| Dec 1, 2025 | John Q Doyle | Sale | 21,079 | $182.22 |
MRSH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $26.98B | $4.16B | 8.43 | $5.29B |
| Dec 31, 2024 | $24.46B | $4.06B | 8.18 | $4.30B |
| Dec 31, 2023 | $22.74B | $3.76B | 7.53 | $4.26B |
| Dec 31, 2022 | $20.72B | $3.05B | 6.04 | $3.46B |
| Dec 31, 2021 | — | $3.14B | 6.13 | $3.52B |
Latest balance sheet: total assets $59.81B, total liabilities $—, cash $1.84B (as of Sep 30, 2026).
MRSH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 15, 2026 | 8-K Item 2.02 (results) | $186.54 |
| Jul 21, 2026 | 8-K Item 2.02 (results) | $181.59 |
| Apr 16, 2026 | 8-K Item 2.02 (results) | $182.57 |
| Jan 29, 2026 | 8-K Item 2.02 (results) | $187.92 |
| Oct 16, 2025 | 8-K Item 2.02 (results) | $186.48 |
| Jul 17, 2025 | 8-K Item 2.02 (results) | $211.04 |
| Apr 17, 2025 | 8-K Item 2.02 (results) | $220.07 |
| Jan 30, 2025 | 8-K Item 2.02 (results) | $220.83 |
| Oct 17, 2024 | 8-K Item 2.02 (results) | $226.92 |
| Jul 18, 2024 | 8-K Item 2.02 (results) | — |
| Apr 18, 2024 | 8-K Item 2.02 (results) | — |
| Jan 25, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Insurance Agents, Brokers & Service
Aon (AON)Arthur J. Gallagher (AJG)Equitable (EQH)Brown & Brown (BRO)Willis Towers Watson (WTW)Ryan Specialty (RYAN)Baldwin Insurance (BWIN)Ethos Technologies (LIFE)Erie Indemnity (ERIE)Goosehead Insurance (GSHD)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MRSH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.